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This study was undertaken to determine how dopamine influ-
ences cortical development. It focused on morphogenesis of
GABAergic neurons that contained the calcium-binding protein
parvalbumin (PV). Organotypic slices of frontoparietal cortex
were taken from neonatal rats, cultured with or without dopa-
mine, harvested daily (4–30 d), and immunostained for parval-
bumin. Expression of parvalbumin occurred in the same re-
gional and laminar sequence as in vivo. Expression in cingulate
and entorhinal preceded that in lateral frontoparietal cortices.
Laminar expression progressed from layer V to VI and finally
II-IV. Somal labeling preceded fiber labeling by 2 d.
Dopamine accelerated PV expression. In treated slices, a
dense band of PV-immunoreactive neurons appeared in layer V
at 7 d in vitro (DIV), and in all layers of frontoparietal cortex at 14
DIV, whereas in control slices such labeling did not appear until
14 and 21 DIV, respectively. The laminar distribution and den-
dritic branching of PV-immunoreactive neurons were quanti-
fied. More labeled neurons were in the superficial layers, and
their dendritic arborizations were significantly increased by do-
pamine. Treatment with a D1 receptor agonist had little effect,
whereas a D2 agonist mimicked dopamine’s effects. Likewise,
the D2 but not the D1 antagonist blocked dopamine-induced
changes, indicating that they were mediated primarily by D2
receptors.
Parvalbumin expression was accelerated by dopaminergic
reinnervation of cortical slices that were cocultured with mes-
encephalic slices.
Coapplication of the glutamate NMDA receptor antagonist
MK801 or AP5 blocked dopamine-induced increases in den-
dritic branching, suggesting that changes were mediated partly
by interaction with glutamate to alter cortical excitability.
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Early perturbations to neurotransmitters that regulate cortical
development change the time course and outcome of corticogen-
esis. Prenatally altered catecholamine levels cause persistent
changes in dendritic morphology of pyramidal neurons, numbers
of GABAergic neurons, and dendritic lengths of interneurons
(Wang et al., 1995, 1996; Jones et al., 1996). Neonatal monoamine
depletion delays normal cortical lamination (Osterheld-Haas and
Hornung, 1996). These developmental influences may be medi-
ated by transmitter-induced alterations of neuronal activity.
Subsets of GABAergic neurons contain calcium-binding pro-
teins (Celio, 1986, 1990; Hendry et al., 1989; van Brederode et al.,
1990, 1991; DeFelipe, 1993; Conde et al., 1994) that may protect
developing neurons against fluctuating levels of metabolic activity
by buffering intracellular calcium (Seto-Ohshima et al., 1990;
Lukas and Jones, 1994). Parvalbumin (PV), a calcium-binding
protein in basket and chandelier cells (Hendry et al., 1989; De-
Felipe, 1993), is thought to regulate intracellular free calcium
fluctuations caused by membrane depolarization (Chard et al.,
1993). Parvalbumin expression occurs late in rodent and primate
development through a sequence of postnatal events (Hendrick-
son et al., 1991; Alcantara et al., 1993; Yan et al., 1995; Berger and
Alvarez, 1996): somata appear first in layer V, then in layer VI,
and finally in superficial layers. Fiber labeling, including pericel-
lular baskets, succeeds that of somata by ;2 d.
Parvalbumin expression is linked to neuronal activity in adult
and developing cortex. Parvalbumin-containing neurons occur in
areas of high metabolic activity, such as cytochrome oxidase-rich
blobs of visual cortex (Celio et al., 1986) and barrels of somato-
sensory cortex (Cohen et al., 1993). Conversely, chronic monoc-
ular deprivation in adult primates causes decreases in PV and
cytochrome oxidase staining in the deprived ocular dominance
column (Gutierrez and Cusick, 1994; Carder et al., 1996). Indi-
vidual neurons in barrel cortex stain intensely for 2-deoxyglucose
and PV (Maier and McCasland, 1997). Furthermore, PV is local-
ized in fast spiking cells of rodent cortex (Kawaguchi et al., 1987;
Kawaguchi and Kubota, 1993, 1997). In the developing monkey
striate and rat visual cortex, PV expression begins in late fetal life
but increases with postnatal onset of visual function (Hendrick-
son et al., 1991; Solbach and Celio, 1991). Conversely, decreased
activity induced by monocular deprivation during the critical pe-
riod of development in rats leads to reduced PV expression in the
cortex contralateral to the deprived eye (Cellerino et al., 1992).
It seems then that neurotransmitter-induced increases in cor-
tical activity will enhance PV expression. Dopamine (DA) may
increase cortical activity by activation of adenylate cyclase, which
enhances glutamate channel conductivity (McMahon et al.,
1994). Dopamine innervation of rodent cortex begins prenatally,
but peaks at approximately postnatal day (PN) 14 (Berger et al.,
1983). D1 and D2 receptor mRNA expression also peaks late (PN
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Figure 1. Micrographs of frontoparietal
cortical slices stained for PV-ir (all with the
pial surface toward the top). A, A slice
culture treated with DA and harvested at 7
DIV. A dense band of PV-ir neuronal so-
mata with labeled dendrites is evident in
layer V, and a few lightly labeled cells are
evident in layer VI. B, An untreated sister
culture harvested at 14 DIV. The pattern of
labeling for PV is similar to that in the 7
DIV DA-treated culture. C, A slice culture,
treated with DA and harvested at 14 DIV.
The dense band of PV-ir neuronal somata
in layer V and the neurons in layer VI have
extensive dendritic labeling. PV-ir neurons
are seen throughout the superficial laminae,
and some of these cells have labeled den-
drites. D, An untreated sister culture har-
vested at 21 DIV. The pattern of PV label-
ing is similar to that in the 14 DIV DA-
treated culture. E, F, The laminar
distribution of PV-ir neurons in a low mag-
nification of the slices shown in C and D,
respectively. Roman numerals denote lami-
nar boundaries. Scale bars: in D for A–D, 50
mm; in F for E, F, 600 mm.
Table 1. Culture treatments
Trial 1 Trial 2 Trial 3 Trial 4
Control medium Control medium Control medium Control medium
10 mM DAa 10 mM DA 10 mM DA 10 mM DA
1 mM DA 1 mM Quinpiroleb 10 mM DA and 1 mM eticlopridec 10 mM DA and 1 mM MK 801d
Ascorbic acide 1 mM SK&F 38393f 10 mM DA and 1 mM SCH23390g 1 mM MK 801
10 mM DA and 1 mM SCH23390
and 1 mM eticlopride
100 mM AP5h
Stock solutions were stored for a maximum of 1 week at 4°C and diluted to working concentrations in control medium at the time of medium exchanges. Each group consists
of 12–16 slices, half of which were harvested at 7 or 14 DIV.
aDA HCl in 0.01% ascorbic acid in H2O, stock solution 5 10 mM.
bQuinpirole, a selective D2 agonist, in H2O, stock solution 5 1.0 mM.
cEticlopride, a selective D2 antagonist, in H2O, stock solution 5 1.0 mM.
dMK801, an NMDA receptor antagonist, in H2O, stock solution 5 1.0 mM.
eAscorbic acid 0.01% in H2O.
fSK&F, a selective D1 agonist, in H2O, stock solution 5 1.0 mM.
gSCH 23390, a selective D2 antagonist, in H2O, stock solution 5 1.0 mM.
hAP5, an NMDA receptor antagonist, in H2O, stock solution 5 100 mM.
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7–30) (Leslie et al., 1991; Schambra et al., 1994). Timing of these
events suggests that the mesocortical DA system modulates PV
expression through mechanisms that increase cortical activity,
such as synaptogenesis, receptor activation, or glutamatergic in-
teractions. This study was undertaken to determine whether DA
affects the morphogenesis of GABAergic neurons that contain
PV, and the mechanisms mediating these changes.
MATERIALS AND METHODS
Organotypic slice cultures were prepared from neonatal rats aged PN 2
or 3. All animal procedures were approved by the Institutional Commit-
tee for Evaluation of Animal Care and Use and were in compliance with
National Institutes of Health Guidelines for the Care and Use of Ani-
mals. The pups were anesthetized by hypothermia and then quickly
decapitated under aseptic conditions. The brains were rapidly removed
and placed into cold sterile MEM (Life Technologies, Gaithersburg,
MD) with 200 mM Tris buffer (dissecting medium). The brains were
hemisected mid-sagittally. Coronal cuts were made to remove portions of
the rostral and caudal poles, leaving the frontoparietal region intact.
Midline and lateral regions of the cortex were included in the slices,
whereas subcortical structures were cut away. The overlying pia was
gently removed. The right and left cortices were cut simultaneously in the
coronal plane at a thickness of 250 mm with a McIlwain tissue chopper.
The slices were transferred into dissecting medium and separated gently
by agitation with a fire-polished glass pipette. Three or four slices were
placed into a Millicell-CM (Millipore, Bedford, MA) insert that was
immersed in dissecting medium. Four inserts were placed together in a
single sterile Petri dish and designated as a control or treatment group to
ensure that the 12–16 slices in each group were cultured under identical
conditions. The control and treatment groups for a single trial were
obtained from the same litter, prepared at the same time, and cultured
for the same durations. Dissecting medium was replaced with culture
medium [MEM supplemented with 25% normal horse serum (NHS)
(Life Technologies) and 200 nM glutamine]. Slices were maintained in
medium at a level that provided an air–medium interface (Stoppini et al.,
1991), in a humid atmosphere at 35°C, in 5% CO2. Medium was re-
freshed every 2–3 d by removing half of the existing medium and
replacing it with fresh medium. Serum levels were reduced to 15% after
1 week. Culture medium alone was used as control medium in all trials.
The following pharmacological treatments were applied: for Trial 1,
slices were treated with DA (1 mM, 10 mM) or ascorbic acid (0.01%; to
slow DA decomposition), the vehicle for DA. The decomposition of
exogenous DA is slowed considerably by the addition of tissue or ascorbic
acid to culture medium (0–19% decay over 3 hr) (Marien et al., 1984) and
even more so by the addition of both tissue and ascorbic acid in buffer
(3–10% over 6 hr in buffer) (Heikkila and Cabbat, 1983). For Trial 2,
slices were treated with DA (10 mM) or the D1 (SK&F 38393; 1 mM) or
D2 (quinpirole; 1 mM) receptor agonist. For Trial 3, slices were treated
with DA (10 mM), DA and either the D1 (SCH 23390; 1 mM, 10 mM) or
the D2 (eticlopride; 1 mM, 10 mM), or both receptor antagonists. For Trial
4, slices were treated with DA (10 mM), DA and MK801 (1 mM), DA and
AP5 (100 mM), MK801, or AP5. Treatments are summarized in Table 1.
In all instances, the treatments were applied throughout the entire
cultivation period. Each trial was repeated at least four times using
different litters. Fresh stock solutions were prepared at 1 week intervals.
Initially, cortical slice cultures grown in control medium or treated with
DA were harvested daily at 4 through 14, 21, 26, and 30 d in vitro (DIV).
Subsequently, for Trials 1–4, slices were harvested at 7 and 14 DIV only,
by removing two of four inserts from each group at these time points.
Cortical and mesencephalic slices were cocultured to allow dopami-
nergic reinnervation of the cortex. Slices of the midbrain, containing
substantia nigra pars compacta, were collected from brains prepared as
described above, cut in the coronal plane at 300 mm, and placed in a
Millicell insert adjacent to a cortical slice taken from a litter mate. The
ventrolateral surface of the midbrain was placed ;0.5–1 mm away from
the pial surface of the cortex. Control cocultures were prepared by
placing the cortex and midbrain slices in separate inserts but in the same
Figure 2. Micrographs showing axonal
labeling in slice cultures maintained for 14
DIV. A, PV-ir axons in deep layer III of
an untreated culture. Note that the axonal
labeling is light, even in deep portions of
layer III. B, PV-ir axons in layer V of an
untreated culture. The labeling is more
prominent in varicosities than in the in-
tervaricose segments. Pericellular baskets
are partially defined at this time point. C,
PV-ir axons in layer III of a DA-treated
culture. The labeling is more dense than
that seen in the untreated culture in A.
The varicosities are heavily labeled and
the intervaricose segments are sparsely
labeled. The pericellular basket pattern is
visible, but weakly defined at this time
point. D, PV-ir axons in layer V of DA-
treated culture. The density of axonal la-
beling is high, and heavy labeling is evi-
dent in both varicose and intervaricose
segments. The pericellular basket is seen
enveloping an unlabeled somata and its
proximal dendrites. Scale bar (shown in D
for A–D): 15 mm.
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Petri dish. Initially, the cocultures were maintained in serum-enhanced
MEM for 1–17 d to determine the time course and pattern of DA
reinnervation. Subsequently, control and cocultures were harvested at 14
DIV for examination of PV expression.
The slices and cocultures were fixed by immersion in 4% paraformal-
dehyde, rinsed in 0.1 M phosphate buffer (2 3 15 min), and subsequently
processed for immunohistochemical detection of various neuronal mark-
ers as follows. Slices were preincubated in 2% normal rabbit serum, in
0.05 M Tris buffer and 0.6% NaCl with 0.2% Triton X-100 for 50 min,
and incubated for 24–48 hr at 4°C in primary antibody (Ab) against
the calcium-binding proteins PV, calbindin, or calretinin (dilution for
all, 1:5000; SWant, Bellinzona, Switzerland), or cytoskeletal proteins
[medium-size neurofilaments clone FNP7, dilution 1:1000 (Zymed, San
Francisco, CA), or the microtubule-associated proteins MAP2a1b clone
AP14, dilution 1:20 (gift from Dr. B. Riederer, Universite´ de Lausanne)].
Cocultures were processed for dual immunostaining (cobalt chloride and
nickel enhancements) of tyrosine hydroxylase (TH; 1:10,000; mouse
monoclonal, Incstar, Stillwater, MN) and PV. The primary antibodies
were detected with the use of biotinylated secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) and the Vector-Elite ABC kit (Vec-
tor Laboratories, Burlingame, CA). The slices and cocultures were
mounted on glass slides, dried, dehydrated, and covered.
Tissue was examined with a Nikon microscope, outfitted with a
computer-driven stage controller. All cortical regions in the slices were
examined histologically, but quantitative analysis was performed only on
frontoparietal regions of the slices. The digitized images were recorded
and analyzed with the Neurolucida Image Analysis (MicroBrightfield)
software program. For each trial, the laminar distribution of PV-
immunoreactive (PV-ir) neurons was determined for experimental and
control groups of slices harvested at 14 DIV. The locations of labeled
neurons in each slice were plotted from the digitized images relative to
the distance between the white matter and the pial surface. The percent-
age of labeled neurons within each 10% increment in distance from the
pial surface were calculated for each slice. The distributions of labeled
neurons in slices from each experimental group were compared with that
of control slices (Student’s t test). Approximate laminar boundaries were
determined from a cytoarchitectonic study of cultured slices, prepared in
the same manner and harvested at the same time points as in the present
study, then stained for Nissl (J-P Hornung, unpublished observations) in
which laminar boundaries were correlated to percentage depth from the
pia to the white matter. Layer I corresponded to 0–10%, layers II–III
corresponded to 10–40%, layer V corresponded to 50–70%, and layer
VI corresponded to 80–100% of depth. No attempt was made to dis-
criminate layer IV from layers II–III, because many slices were from
agranular frontal regions.
In addition, for each trial the dendritic branching patterns of PV-ir
neurons were determined in slices harvested at 14 DIV. Ten cells per
treatment were randomly selected from among the most intensely labeled
neurons that were located in layer V of frontoparietal cortex. Their
dendritic arbors were reconstructed on high-magnification video-
captured images with the Neurolucida software program. An automated
Scholl analysis was performed on each of the reconstructed neurons to
measure the number of intersections between dendrites and concentric
radii (20 mm intervals) drawn relative to the soma. In addition, the sum
of lengths of all dendrites within each concentric radius was calculated
from the reconstructions. These measures of dendritic arborization were
compared between experimental and control groups of slices (Student’s
t test).
RESULTS
Dopamine specifically modulates the expression of PV
in cortical neurons during development
To screen for neuronal proteins whose expression would be
affected by the presence of DA, an immunocytochemical analysis
of DA-treated and control slices at 14 DIV was performed, using
markers for interneurons (calbindin, parvalbumin, calretinin) and
pyramidal neurons (neurofilaments, MAP2a1b). All proteins
were readily detected in the cultures (data not shown) and were
localized in the predicted cell types. Of all the markers, only PV
appeared to have an expression and distribution altered by the
DA treatment, as described below. Therefore, the quantitative
assessments focused only on PV-labeled slices.
In the control slices, PV-ir neurons first appeared in the deep
laminae of cingulate and perirhinal cortices at 6 DIV. At this
time, these neurons had only their somata immunolabeled. Both
PV-ir dendrites and axons (as evidenced by beaded fibers in the
neuropil) were observed around these neurons at 8 DIV.
Parvalbumin-ir somata appeared next in the superficial layers of
the cingulate and perirhinal cortices at 7 DIV, and a band of
sparse PV-ir somata in layer V first appeared in frontoparietal
cortex at 8 DIV. Dendritic branches on labeled somata and well
labeled fibers in the neuropil began to appear 2 d after the
appearance of labeled somata in each region and layer, and fiber
labeling in the surrounding neuropil continued to increase in
density over the next several days. The PV-ir somata appeared
next in deeper portions (layer VI) of frontoparietal cortex at 12
DIV. Labeling of dendrites of deeper layer VI and axonal spe-
cializations in more superficial layer V neurons were not apparent
until 14 DIV. Thus, after 14 d in culture, PV-ir somata, dendrites,
and axons were observed throughout all layers of the cingulate
and perirhinal regions but were mostly limited to the deep lam-
inae of the frontoparietal regions (Fig. 1B). Pericellular axonal
Table 2. Sequence of parvalbumin expression
DIV
4 5 6 7 8 9 10 11 12 13 14 21 26 30
Control
cultures 1 2 3 4 5 6 7 9 13 14
8 10
11
Dopamine-
treated
cultures 1 2 3 7 8 11 13
4 9 12 14
5 10
6
1, Somata in layers V–VI of cingulate/perirhinal cortex; 2, somata in layers II–III of cingulate/perirhinal cortex; discontinuous band of somata in layer V of frontoparietal
cortex 3, continuous band of somata in layer V of frontoparietal cortex; 4, sparse fibers in layer V of frontoparietal cortex; 5, somata with dendrites and dense fibers in layer
V of frontoparietal cortex; 6, somata in layer VI of frontoparietal cortex; 7, somata with dendrites in layer VI of frontoparietal cortex; 8, pericellular axonal baskets in layer
V of frontoparietal cortex; 9, somata in layers II–III of frontoparietal cortex; 10, sparse fibers in layers II–III of frontoparietal cortex; 11, dense fibers and pericellular baskets
in layers II–III of frontoparietal cortex; 12, somata with dendrites in layers II–III of frontoparietal cortex; 13, horizontal band of axons in layer I of frontoparietal cortex;
bilaminar distribution of somata in II and V–VI of frontoparietal cortex; 14, dense axons and extensive dendrites in layers I–VI of frontoparietal cortex.
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baskets were found in the deep laminae of frontoparietal cortex at
this time, but they were extremely difficult to distinguish, even in
deeper portions of the superficial laminae (Fig. 2A,B), and axons
were not visible in upper layer III and layer II. By 21 DIV a dense
population of extensively labeled neurons and fibers were noted
in layers V and VI, and both well labeled neurons (somata and
dendritic label) and fibers had extended throughout the superfi-
cial layers II–IV (Fig. 1D,F). At 26 DIV, fiber staining in super-
ficial laminae was more dense (data not shown).
The DA-treated slices exhibited a similar pattern of emergence
of PV expression, but labeled profiles appeared at consistently
earlier time points. At 4 DIV, the earliest time examined, labeled
somata with dendrites were already present in the deep layers of
cingulate and perirhinal cortices. By 6 DIV, some labeled somata
were also present in the superficial layers of cingulate and perirhi-
nal cortex, and a few scattered PV-ir neurons were present in
layer V of frontoparietal cortex. On the following day, 7 DIV, a
band of neurons containing label in both their somata and den-
drites was observed in layer V throughout the frontoparietal
cortex. Lightly labeled neuronal somata were also observed in
layer VI at this time point (Fig. 1A). The layer VI neurons
exhibited labeled dendrites by 9 DIV. The number of labeled
neurons and the density of labeled fibers in both layers V and VI
increased gradually over the next several days. Parvalbumin-ir
somata appeared in the superficial laminae at 13 DIV, with a few
labeled axons and dendrites also apparent at this time. Dense
dendrites and axonal specializations in the surrounding neuropil
were first noted to be immunostained at 14 DIV. The density of
labeled profiles continued to increase over the next several days.
Thus, at 2 weeks, neurons with labeled dendrites and labeled
axons in the neuropil were clearly evident throughout all cellular
layers of the frontoparietal region (Fig. 1C,E), with the most
extensive dendritic labeling and fiber labeling in the deep layers.
Intricate pericellular baskets were observed in the deep laminae,
but distinguishable baskets were commonly observed throughout
the superficial laminae as well (Fig. 2C,D). At 21 DIV, the density
of label was further increased, and a dense band of horizontal
fibers was evident in layer I (data not shown). These features did
Figure 3. Micrographs of 14 DIV sister
cultures stained for PV. A, Laminar distri-
bution of PV-ir neurons in an untreated
slice. A dense band of PV-ir neurons is in
layer V. These neurons have labeled den-
drites. A few labeled somata are seen in
layer VI, and scattered somata with light
labeling are seen in the superficial layers.
B, Higher magnification of layers V–VI of
the slice in A. Dendritic labeling is evident
on most PV-ir neurons. Fiber labeling in
the neuropil is moderate. C, DA-treated
slice showing the laminar distribution of
labeled neurons. Parvalbumin-ir neurons
with extensive dendritic labeling are visible
in layers V and VI. Both neuronal and
fiber labeling are visible in the superficial
layers. D, Higher magnification of layers
V–VI of the slice in C. Extensive dendritic
labeling is evident on most PV-ir neurons.
Fiber labeling in the neuropil is dense.
Roman numerals denote laminar bound-
aries. Scale bars: in C for A, C, 150 mm: in
D for B, D, 20 mm.
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not show significant changes when examined at later times. The
developmental sequence of events for cortical expression of PV
and the time of their emergence in the control and DA-treated
slices are summarized in Table 2. The lower dose of DA (1 mM)
was only minimally effective in mediating changes in PV expres-
sion. Although our culture conditions (tissue and ascorbic acid)
may be optimal for slowing the decomposition rate of DA (Heik-
kila and Cabbat, 1983; Marien et al., 1984), this lower dose may
not have been stable for a sufficient time to be effective, as was the
10 mM DA treatment. Vehicle (ascorbic acid)-treated slice cul-
tures showed the same time course of PV expression as did the
control slices.
The effects of DA on PV expression are differentially
mediated by the dopamine D1 and D2 receptors
The laminar distribution and dendritic branching patterns of
PV-ir neurons in control slices were compared with the slices
treated with DA, vehicle, D1 or D2 receptor agonists, and DA 1
D1 or DA 1 D2 antagonists at 14 DIV. In the DA-treated slices,
a greater proportion of labeled neurons appeared to be in the
superficial layers, and PV-ir neurons appeared to have more
extensive dendritic arbors than those of control slices (Fig. 3).
Although the D1 agonist treatment did not mimic the effects of
DA, the D2 agonist-treated slices showed a shift in the distribu-
tion of PV-ir neurons toward the superficial layers and an increase
in dendritic labeling similar to that seen with the DA treatment
(Fig. 4). A quantitative analysis showed that DA significantly
altered the laminar distribution of labeled neurons across all
intervals (Student’s t test, p 5 0.00065) as compared with un-
treated slices. In the DA-treated slices, a higher percentage of
PV-ir neurons were located at intervals of cortical depth that
corresponded to the superficial layers (Fig. 5A). The D1 agonist
treatment did not cause significant changes in laminar distribu-
tion of labeled neurons, but the D2 agonist treatment caused a
shift in distribution of PV-ir neurons toward the superficial layers
in comparison to control slices (Student’s t test, p 5 0.014).
Ascorbic acid treatment had little effect on laminar distribution of
PV-ir neurons.
Figure 4. Micrographs of PV-ir neurons in
14 DIV sister cultures. A, Labeled neurons
in an untreated culture form a band in layer
V with a few scattered neurons also visible
in VI and II–III. B, Labeled neurons in a
DA-treated culture are dense in all layers.
C, Labeled neurons in a D1 agonist-treated
culture form a band in layer V with a few
scattered neurons also visible in VI. D, La-
beled neurons in a D2 agonist-treated cul-
ture form a band in layer V with numerous
neurons also visible in VI and III. E, High
magnification of PV-ir neurons in layer V of
the slice shown in C. Many somata are la-
beled, but only a few neurons show exten-
sive dendritic branching. F, High magnifica-
tion of PV-ir neurons in layer V of the slice
shown in D. Many somata with extensive
dendritic labeling are visible. Fiber labeling
in the neuropil is dense. Scale bars: in D for
A–D, 50 mm; in F for E, F, 20 mm.
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Dopamine treatment also affected the dendritic arborizations
of PV-ir neurons. This effect appeared to be mediated primarily
by D2 receptors. Dopamine treatment resulted in a significant
increase in dendritic length (Student’s t test, p 5 0.0033) (Fig. 5B)
and in the number of dendritic intersections (Student’s t test, p 5
0.0000045) (Fig. 5C) within concentric radial intervals (20 mm)
from the somata as compared with controls. Moreover, the long-
est labeled dendrites by far, extending up to 520 mm in length,
were observed only on neurons in the DA-treated slices (data not
shown). The D2 agonist treatment also caused consistent overall
increases in dendritic length and number of intersections (Stu-
dent’s t test, p 5 0.000087 and 0.000154, respectively) as com-
pared with controls. The increases in dendritic length induced by
the D2 agonist treatment is evident in Figure 5B. The D1 agonist
caused no significant changes in either the length of dendrites or
the number of dendritic intersections either overall or at any
individual radial distances. Ascorbic acid treatment had no sig-
nificant effect on either measure of dendritic arborization of
PV-ir neurons.
Trials in which slices were treated with DA and the D1 antag-
onist SCH 23390 or with DA and the D2 antagonist eticlopride
also indicated that the DA-induced changes in PV expression
were primarily mediated by D2 receptors. Coapplication of the
D1 antagonist with DA was ineffective in blocking DA-induced
changes, but the D2 antagonist appeared to block the DA-
induced shift in laminar distribution and increase in fiber density
(Fig. 6). A quantitative analysis showed that PV expression in
slices treated with DA and the D1 antagonist was not significantly
different from slices treated with DA only. Measures for dendritic
intersections and lengths/concentric radii are shown in Figure 7.
These same measures were significantly different between the DA
1 D2 antagonist-treated slices and the DA-only-treated slices
(Student’s t test, p 5 0.000035 for intersections, 0.00024 for
lengths). In slices treated with both the D1 and D2 antagonists,
Figure 5. Histograms of the depth distribution and the
dendritic branching patterns of PV-ir neurons in slices from
the agonist trials that were maintained for 14 DIV. A, The
distribution of PV-ir neurons is shown relative to the depth
from the pial surface. The DA-treated slices had a higher
percentage of neurons in the superficial laminae than in
control slices. The other treatment groups were not signif-
icantly different from controls. B, The lengths of labeled
dendrites at concentric radii from the soma are shown.
Neurons in the DA-treated slices showed an increase in
dendritic lengths overall and at all individual concentric
radii compared with controls. Quinpirole treatment showed
a slight increase in dendritic lengths at all radial distances
but was significantly different only at 100 mm from the soma.
C, The number of intersections at concentric radii from the
soma are shown. DA- and quinpirole-treated slices showed
significant increases in dendritic branching of PV-ir neu-
rons overall and at many individual radial distances. Den-
dritic intersections with concentric radii were noted up to
520 mm from the soma in the DA-treated group but only up
to 360 mm in other groups (*p , 0.05; Student’s t test).
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the density and laminar distribution of PV-ir neurons appeared to
be similar to that of untreated slices (Fig. 8). Indeed, quantitative
analysis showed no significant differences between controls and
the dual antagonist-treated group. The laminar distribution of
PV-ir neurons for these trials is shown in Figure 9.
Changes in PV expression may be mediated by
DA–glutamate interactions
Cortical slices were treated with the glutamate NMDA receptor
antagonists MK801 or AP5 to determine whether the effects of
DA on PV expression were linked to DA-mediated changes in
cortical excitability. Both MK801 and AP5 were effective in
substantially blocking the DA-induced changes in laminar distri-
bution and dendritic branching patterns of PV-ir neurons. The
increase in percentage of PV-ir neurons in the superficial cortical
layers at 14 DIV induced by DA treatment was attenuated in
slices treated with both DA and MK801. Treatment with the
antagonists alone had little effect on the laminar distribution of
labeled neurons as compared with controls. Slices from the
MK801 trials illustrate these effects (Fig. 10). A quantitative
analysis of the depth distribution of PV-ir neurons showed that
DA alone induced a significant increase in the percentage of
PV-ir neurons in the superficial layers, concomitant with a de-
crease in the deeper layers. Although the addition of MK-801
with DA attenuated the laminar shift, it did not fully block the
effect, in that the portion of labeled neurons in the superficial
layers remained significantly increased compared with controls in
the superficial layers (20–40% uppermost part of total cortical
depth) and decreased in portions of the deeper layers (60% of
depth) (Fig. 11A). MK801 was effective in blocking the DA-
induced increases in dendritic arborizations of PV-ir neurons as
illustrated in Figure 11B,C. Similar findings were observed with
the AP-5 trials. Coapplication of AP5 with DA effectively blocked
the laminar shift in PV-ir neuron distribution. In addition, the
density of neurons in each lamina of the AP5 1 DA-treated slices
was reduced in comparison to DA-treated slices but similar to
that in controls (Fig. 12). The number of neurons per layer was
significantly lower in both of these groups than in the DA-only
slices ( p 5 0.0004 for DA vs DA 1 AP5 and p 5 0.00038 for DA
vs NHS).
Parvalbumin expression is accelerated by the ingrowth
of dopaminergic fibers
Dopaminergic reinnervation to the developing cortex was estab-
lished with the mesencephalon–cortical cocultures. The charac-
teristics of DA fiber ingrowth at daily time points were examined.
At DIV 1–2, the axotomized DA fibers that were present at the
time of culture preparation remained in the deep laminae of the
cortex. By DIV 3 all of these fibers had virtually disappeared, and
TH-positive fibers from the midbrain slice had reached the pial
surface of the cortical slice. Fibers crossed from the mesence-
phalic slice, entered the cortex over the next few days (Fig. 13),
and initially ran in two bundles: one bundle of fibers ran radially
down to enter the white matter, and a second bundle ran hori-
zontally in layer I. From DIV 5 to 8, TH-positive fibers entered
the deep laminae from the white matter and extended along the
horizontal axis of the slice. These fibers arborized extensively
over the next few days, and some branches reached into the
superficial layers where they also began to branch. The deep
laminae remained the most densely innervated. The bundle of
fibers that extended into layer I early in the cocultures remained
in this position. Its horizontal extent lagged behind that of the
deeply running fiber bundle. Eventually a mature bilaminar pat-
tern of fibers emerged.
The reinnervation of cortical slices with DA axons accelerated
PV expression in comparison to cortical slices cultured without an
adjacent midbrain slice (Student’s t test, p 5 0.00054 for laminar
distribution). At 14 DIV, the laminar distribution of PV-ir neu-
rons was comparable to that of cortical slices treated with DA (no
significant difference) in that labeled neurons were observed not
only in the deep, but also in the superficial cortical layers (Fig.
14). Furthermore, the increased density of labeled neurons seen
with DA-treated cortical slices was evident in the reinnervated
cocultures as well (Fig. 15).
Figure 6. Micrographs of PV-ir neurons in 14 DIV sister cultures from the DA receptor antagonist trial. These cultures were prepared from PN 4 pups
and are slightly more mature than those in other micrographs. A, Labeled neurons in an untreated culture form a dense band in layer V with numerous
neurons in layer VI. Only scattered neurons are visible in superficial layers. B, Labeled neurons in a DA-treated culture are dense and have elaborate
dendritic arbors in all layers. C, Labeled neurons in a DA 1 D1 antagonist-treated culture are visible throughout all laminae. D, Labeled neurons in a
DA 1 D2 antagonist-treated culture form a dense band in layer V with numerous neurons also visible in VI, but only scattered neurons in layers II–III.
Roman numerals denote laminar boundaries. Scale bar (shown in D for A–D): 100 mm.
Porter et al. • Dopamine Affects Parvalbumin Expression J. Neurosci., October 15, 1999, 19(20):8990–9003 8997
DISCUSSION
Parvalbumin expression follows similar sequential events in vitro
and in vivo. Dopamine, acting preferentially at D2 receptors,
accelerates developmental expression of PV. Ingrowth of dopa-
minergic axons in the coculture system also accelerates PV ex-
pression. MK801 and AP5 block the effects of DA on PV
expression.
Technical considerations
Organotypic slice cultures are ideal for studying developmental
events mediated by connectivity and exogenous influences in
isolated systems. Features of intrinsic organization such as neu-
ronal morphology and cytoarchitecture are maintained (Bolz et
al., 1990; Stoppini et al., 1991; Ga¨hwiler et al., 1997).
Parvalbumin-ir neurons, in particular, maintain similar densities
in organotypic cultures as in vivo (Weisenhorn et al., 1998).
Moreover, neurons cocultured with target tissues form appropri-
ate efferent connections (Bolz et al., 1990, 1992). Afferents dis-
tribute to and synapse with appropriate targets (Frotscher et al.,
1995). Although difficult to assess morphologically, functional
intrinsic connections are detectable physiologically: long-term
potentiation in hippocampal cultures (Stoppini et al., 1991, Mu¨l-
ler et al., 1996). Developmental events occur in response to the
same influences and in the same manner as in vivo: downregula-
tion of neuropeptide Y in vivo and in organotypic cultures that
receive specific (thalamic/cortical) afferents, but not in deaffer-
ented slices (Obst and Wahle, 1997).
Our measurements of dendritic arbors were taken from por-
tions of immunoreactive dendrites that express PV. Because
observations were made during a period of sharp increases in
PV expression, it was not possible to determine whether ob-
served dendritic changes reflected actual morphological changes
or merely differences in PV expression that yield incomplete
dendritic filling. Therefore, although our observed differences
in dendritic measures can be attributed to direct effects of DA
on PV expression, they only suggest that dendritic growth is al-
tered by DA.
Developmental expression of PV in vitro
The developmental sequence of PV expression is similar in or-
ganotypic cultures and in vivo. In the intact rodent cortex, PV
Figure 7. Histograms of the dendritic branching patterns of PV-ir neu-
rons in slices from the DA receptor antagonist trials, which were main-
tained for 14 DIV. A, The lengths of labeled dendrites at concentric radial
distances from the soma are shown. Neurons in the DA-treated slices
showed increased dendritic lengths compared with controls. These mea-
sures were similar in the DA and the DA 1 SCH (D1 antagonist) groups,
but relatively lower in the DA 1 ETIC (D2 antagonist)-treated slices. B,
The number of dendritic intersections at concentric radial distances
measured from the soma are shown. Neurons in the DA-treated slices
showed increased dendritic branching compared with controls. These
measures were similar in the DA and the DA 1 SCH (D1 antagonist)
groups but relatively lower in the DA 1 ETIC (D2 antagonist) groups.
Figure 8. Micrograph of PV-ir neurons in a slice treated with DA and
both the D1 and D2 antagonists and maintained for 14 DIV. A band of
labeled neurons is visible in layer V, but very few labeled neurons appear
in either layer VI or the superficial layers. Roman numerals denote
laminar boundaries. Scale bar, 150 mm.
Figure 9. Histogram showing the laminar distribution of PV-ir neurons,
expressed as percentage of total labeled neurons in each 10% increment
of cortical depth, for slices from the dual antagonists trials. The distribu-
tion of PV-ir neurons is shown relative to the depth from the pial surface.
The DA-treated slices had a higher percentage of neurons in the super-
ficial laminae than the control slices or antagonist-treated slices. The
sparse numbers of labeled neurons in the dual antagonist-treated slices
(Fig. 8) were narrowly clustered in layer V (50–70% depth).
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expression appears first in somata of cingulate and retrosplenial
cortices at PN 8–9 and of occipital, frontoparietal, and temporal
cortices at PN 10–11 (Soriano et al., 1992; Alcantara et al., 1993).
Our findings show similar in vitro events. Cingulate–perirhinal
precedes frontoparietal labeling. Parvalbumin appears sequen-
tially in layers V, VI, and then II–III, with somal preceding
axonal and dendritic labeling. The earlier appearance in layer V
than in VI indicates that expression is not concordant with
neuronal migration and subsequent maturation, because migra-
tion occurs earlier and progresses from layer VI to II (Miller,
1988, Ignacio et al., 1995). Weisenhorn and colleagues (1998)
were able to elicit mature patterns of PV expression only in
organotypic slices of parietal cortex explanted at PN 7 or later,
and not in slices explanted at PN 3. They concluded that extrinsic
influences, such as late onset of tactile responsiveness in sensory
cortex, were needed for normal PV expression. Different findings
may have arisen from variable conditions (serum deprivation
does not alter results in either study), but Plenz and Aertsen
(1996) also achieved mature PV expression patterns in early
organotypic explants (PN 0–2). Our observation that PV expres-
sion is delayed but not prevented in early, untreated cultures
suggests that intrinsic factors trigger PV expression, whereas
extrinsic influences, including DA, accelerate it.
Dopamine accelerates PV expression
If PN age at explant plus time in culture are considered equiva-
lent to age in vivo, then the timing of PV expression in DA-treated
slices, rather than controls, corresponds more closely to that in
intact animals. Slices from PN 2–3 pups maintained for 7 DIV
would be considered 10 d cortices. The PV expression pattern
(dense band in frontoparietal layer V) in these DA-treated slices
corresponds to that in intact animals at PN 10 (Soriano et al.,
1992; Alcantara et al., 1993). This pattern does not occur until
cortical age 16–17 (PN 2–3 donors 1 14 DIV) in controls.
Parvalbumin-ir somata appear in all frontoparietal layers by cor-
tical age 16 d in DA-treated slices and 15 DIV. The appearance
of labeled neurons in cingulate cortex and of somata, fibers, and
baskets in specific laminae also occurs at similar times in vivo and
in DA-treated cultures (Soriano et al., 1992; Alcantara et al.,
1993). This observation is not surprising considering that the
intact cortex is exposed to DA during development. Indeed,
prenatal exposure to cocaine, which increases DA levels by inter-
fering with uptake, increases PV-ir dendrites on interneurons in
cingulate cortex. Interestingly, PV-containing interneurons in vi-
sual cortex, where DA innervation is sparse, are unaffected
(Wang et al., 1996). These studies focused on morphogenesis of
one subset of GABAergic neurons, but DA may affect others.
Neurite extension of cultured primary neurons, which comprise a
mixed neuronal population, is also altered by DA (Reinoso et al.,
1996).
Dopamine reinnervation accelerates PV expression
Although development of the DA system varies across cortical
regions, the pattern of DA innervation in our organotypic cocul-
Figure 10. Micrographs of labeled neurons
in slices from the MK801 trials that were
maintained for 14 DIV. A, An untreated
slice with PV-ir neurons visible as a band in
layer V and a few scattered neurons in layers
VI and III. B, A DA-treated slice with PV-ir
neurons throughout the depth of the slice. C,
An MK801-treated slice with a band of
neurons in layer V, similar to that in the
control. D, A slice treated with DA and
MK801. PV-ir neurons are primarily in a
band in layer V, with scattered neurons in
layers VI and III. Scale bar (shown in D for
A–D): 200 mm.
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ture system mimics that of similar cortical regions in vivo (Lind-
vall et al., 1978). The ingrowth of DA axons in the mesencepha-
lon–cortex cocultures accelerated cortical PV expression in the
same manner as in slices treated with exogenous DA. This ob-
servation suggests that perturbations to the developing DA sys-
tem occurring in intact animals may modulate circuit formation
during the period of PV expression.
D2 receptor mediation of DA-induced effects
Our findings indicate that D2 receptor activation preferentially,
but not exclusively, enhances PV expression. Coapplication of D1
and D2 antagonists is more effective in blocking DA-induced
acceleration of PV expression, suggesting that interaction be-
tween the two receptor subtypes is involved. Developing dopa-
minergic axons and D1 and D2 receptor mRNA expression are
detected well in advance of PV appearance (Verney et al., 1982;
Kalsbeek et al., 1988; Mack et al., 1991; Schambra et al., 1994),
but their peak densities occur at PN 14, 14–30, and 7, respectively
(Schmidt et al., 1982; Berger et al., 1983; Schambra et al., 1994).
Onset of receptor binding, indicating function, occurs concur-
rently (PN 14–21) (Leslie et al., 1991). These similarities to
timing of PV appearance suggest a link between receptor activa-
tion and PV expression. D2 mRNA is widespread in the adult
rodent frontal cortex (Gaspar et al., 1995; Awenowicz and Porter,
1998), but binding is weak (Richfield et al., 1989; Schambra et al.,
1994). Dense adult D2 mRNA suggests the possibility of transient
increases in expression that are correlated with developmental
PV expression.
Although the D2 receptor agonist is implicated in enhancing
PV expression, its mechanism of action is uncertain. Both facili-
tatory and inhibitory responses to D2 receptor activation occur in
the cortex (Bunney and Aghajanian, 1976; Reader et al., 1979;
Sawaguchi et al., 1986; Penit-Soria et al., 1987; Pirot et al., 1992;
Geijo-Barrientos and Pastore, 1995). Facilitatory responses of
glutamatergic neurons could increase cortical excitability, which
has been linked with increased PV expression (Celio et al., 1986;
Hendrickson et al., 1991; Solbach and Celio, 1991; Cohen et al.,
1993), but further studies are needed to determine the mecha-
nisms of D2-mediated effects.
Figure 11. Histograms of the laminar distribution and the
dendritic branching patterns of PV-ir neurons in slices from
the MK801 trials that were maintained for 14 DIV. A, The
distribution of PV-ir neurons is shown relative to the depth
from the pial surface. A higher percentage of neurons is in
the superficial laminae of DA-treated slices in comparison
with controls. Treatment with MK801 in addition to DA did
not block this effect of DA. B, The lengths of PV-ir den-
drites at concentric radii from the soma are shown for each
group. Neurons in the DA-treated slices showed increased
dendritic lengths at all concentric radii examined compared
with controls. MK801 completely blocked the DA-induced
increases in dendritic length. C, The dendritic intersections
at concentric radii from the soma are shown. DA treatment
resulted in an increase in number of intersections at nearly
all radial distances. This effect was blocked by MK801 at all
radial distances, except 40 mm from the soma (*p , 0.05;
Student’s t test).
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Dopamine and glutamate interactions
Our observation that the NMDA receptor antagonists MK801
and AP5 effectively block DA-induced effects on PV expression
suggests that DA alters glutamatergic transmission. DA–gluta-
mate interactions have been observed in slices of human neocor-
tex where DA facilitates glutamate-induced responses in layer V
pyramidal neurons by increasing depolarization and firing rate
and decreasing latency of NMDA-induced EPSPs (Cepeda et al.,
1992). Conversely, DA decreases depolarization and firing fre-
quency of quisqualate-induced EPSPs (Cepeda et al., 1992).
Thus, modulatory effects of DA depend on the glutamate recep-
tor subtype involved. In layer V pyramidal neurons of rodent
cortex, D1 agonists decrease both NMDA and AMPA compo-
nents of EPSPs (Law-Tho et al., 1994). Interactions may differ
during development. In prefrontal cortex of young but not of aged
rats, nonspecific DA receptor activation increases extracellular
glutamate (Porras et al., 1997). Perhaps this age-related alteration
in DA receptor function reflects unique developmental roles for
receptor subtypes. The predicted presynaptic effects of DA on
glutamatergic transmission (Pralong and Jones, 1993; Law-Tho et
al., 1994) have a putative morphological correlate. Triads, com-
posed of a DA axon terminal, a postsynaptic spine, presumably of
a pyramidal neuron, and an unlabeled asymmetric, presumably
glutamatergic terminal, have been observed in the cortex
(Goldman-Rakic et al., 1989).
Onset of synapse formation is another candidate for regulation
of PV expression. Although the pattern of synaptogenesis in
cortical slices is unknown, synaptic responses are detected early
and increase dramatically at 2–3 weeks in hippocampal cultures
(Stoppini et al., 1991). A recent study shows that synaptic matu-
ration is accelerated by DA (Rizzo et al., 1998) and supports the
notion that increased activity enhances PV expression.
Although PV expression occurs regardless of the presence of
DA, it is increased and accelerated by DA in vivo (Wang et al.,
1996) and in vitro (present study). The extent of dopaminergic
innervation varies between species, projecting preferentially to
medial frontal cortex in rodents but to the entire frontal lobe in
primates (Berger and Gaspar, 1994). Thus, perturbations to the
DA system might have broader effects on primate cortical devel-
opment than that in rodents.
Figure 12. Histogram showing the laminar distribution of PV-ir neurons
expressed as percentage of total labeled neurons in each 10% increment
of cortical depth, in slices from the AP5 trials. The distribution of PV-ir
neurons is shown relative to the depth from the pial surface. The DA-
treated slices had a higher percentage of neurons in the superficial
laminae than in control slices or those treated with DA 1 AP5.
Figure 13. Micrographs of a cortex–mesencephalon coculture immuno-
stained for TH. The cortex is at the top in A and B. A, Coculture showing
TH-labeled fibers crossing the gap between the two slices. B, High
magnification of the same coculture showing dense TH-labeled fibers in
the cortex. Scale bar, 200 mm.
Figure 14. Graph showing the laminar distribution and density of PV-ir
neurons, expressed as number of labeled neurons in each 10% increment
of cortical depth, in the coculture trials. The distribution of PV-ir neurons
is shown relative to the depth from the pial surface. The reinnervated
cortices had a greater number of labeled neurons overall and greater
densities in the superficial layers as compared with cortices cultured
separately from mesencephalic slices. These measures were similar, how-
ever, to those in sister cultures treated with exogenous DA.
Figure 15. Micrograph of a cortical slice cocultured with a mesence-
phalic slice, immunostained for both TH and PV. Labeled fibers (arrow-
heads) show the extent of dopaminergic reinnervation. Numerous PV-ir
neurons are visible in all cortical layers. Scale bar, 250 mm.
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